Afferent Pharmaceuticals
-

Merck Buying California-Based Afferent Pharmaceuticals for a Cool $1.25 Billion
Merck has entered into a $1.25 billion deal to acquire California-based Afferent Pharmaceuticals, which is developing a treatment for chronic cough,…
















![ForAll_Digital-Ad_Malaika_376x628[44]](https://montco.today/wp-content/uploads/sites/2/2022/06/ForAll_Digital-Ad_Malaika_376x62844.jpg)













